R&D and ADL centre has certified by DSIR, Govt. of India.
2020-10-16 08:52:49
OSD Plant at Thane has been renewed with WHO GMP Certificate by CDSCO by Government of India
2025-09-01 08:10:04
OSD plant at Thane has been approved by Eurasian authority for EAEU GMP for Tablet, Capsule, Liquid Oral and Ointment & Cream Facility
2025-09-01 08:12:56
Company has Successfully started the opration at its Goa Plant for Oncology Products
Launch of two products in our brand and for contract manufacturing Oseltamavir caps, 30mg, 45mg and 75 mg And Favipiravir 200 mg/400mg/800mg Tablet.
Well established corporate office in Mumbai-India, Moscow-Russia, Kiev-Ukraine, & Minsk-Belarus, Lok-Beta is able to cater regulated market operations in CIS Market covering almost all CIS countries.
The majority of products marketed are for the treatment and/or prevention of chronic and recurrent illness.
For details please visit Product menu
The company has extensive database and obtains regular feedback on customer purchasing patterns and preferences and doctor prescribing habits. These detailed information's are used to direct the company's promotional spend, sales force activity, product development programmes and to identify new product opportunities.